Document and Entity Information
Document and Entity Information | Aug. 07, 2020 |
Cover [Abstract] | |
Entity Registrant Name | MERIDIAN BIOSCIENCE INC |
Amendment Flag | true |
Entity Central Index Key | 0000794172 |
Document Type | 8-K/A |
Document Period End Date | Aug. 7, 2020 |
Entity Incorporation State Country Code | OH |
Entity File Number | 0-14902 |
Entity Tax Identification Number | 31-0888197 |
Entity Address, Address Line One | 3471 River Hills Drive |
Entity Address, City or Town | Cincinnati |
Entity Address, State or Province | OH |
Entity Address, Postal Zip Code | 45244 |
City Area Code | (513) |
Local Phone Number | 271-3700 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, no par value |
Trading Symbol | VIVO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | On August 7, 2020, Meridian Bioscience, Inc. (“Meridian” or the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) under Items 2.02 and 7.01 in connection with the issuance of a press release (the “Release”) announcing results for the third quarter ended June 30, 2020. The Original 8-K included a copy of a presentation related to the Company’s August 7, 2020 conference call (the “Presentation”) and the Release as exhibits. Meridian is filing this Amendment No. 1 on Form 8-K for the purpose of correcting a typographical error included in the Release and Presentation. The references to the diluted share count of 42.2M shares on page 2 of the Release and on slide 7 of the Presentation are replaced by 43.2M shares. |